500 related articles for article (PubMed ID: 11674855)
21. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacological studies of FUT-175, nafamstat mesilate. IV. Effects on coagulation, platelets and fibrinolysis].
Koshiyama Y; Ozeki M; Motoyoshi A; Fujita M; Iwaki M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Nov; 84(5):417-28. PubMed ID: 6519580
[TBL] [Abstract][Full Text] [Related]
23. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
Han F; Yao W; Yang X; Liu X; Gao X
Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
[TBL] [Abstract][Full Text] [Related]
24. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
Mendelsohn EE; Solum NO; Brosstad F
Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
[TBL] [Abstract][Full Text] [Related]
25. [Effects of Angelica polysaccharide on blood coagulation and platelet aggregation].
Yang T; Jia M; Mei Q; Shang P
Zhong Yao Cai; 2002 May; 25(5):344-5. PubMed ID: 12583194
[TBL] [Abstract][Full Text] [Related]
26. The effects of fructose diphosphate on routine coagulation tests in vitro.
Chen T; Chen D; Chen L; Chen Z; Wang B; Zhou D
Sci Rep; 2022 Jan; 12(1):304. PubMed ID: 34997135
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of platelet adherence to mononuclear cells by alpha-tocopherol: role of P-selectin.
Murohara T; Ikeda H; Otsuka Y; Aoki M; Haramaki N; Katoh A; Takajo Y; Imaizumi T
Circulation; 2004 Jul; 110(2):141-8. PubMed ID: 15197142
[TBL] [Abstract][Full Text] [Related]
29. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
30. The effects of aminoglycoside antibiotics on platelet aggregation and blood coagulation.
Chen G; Fei X; Ling J
Clin Appl Thromb Hemost; 2012 Sep; 18(5):538-41. PubMed ID: 22327814
[TBL] [Abstract][Full Text] [Related]
31. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
32. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
[TBL] [Abstract][Full Text] [Related]
33. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
34. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
Dirkmann D; Hanke AA; Görlinger K; Peters J
Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
[TBL] [Abstract][Full Text] [Related]
35. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
Carlsson SC; Schulman S
Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
[TBL] [Abstract][Full Text] [Related]
36. [Dose-effect relationship of traditional Chinese medicine formula for promoting blood circulation to remove stasis on ADP-induced platelet aggregation and rabbit plasma thrombin time].
Zhang Y; Tang Y; Guo J; Ding A; Duan J
Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(21):2821-6. PubMed ID: 20209924
[TBL] [Abstract][Full Text] [Related]
37. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
Roberts PS; Hughes HN; Fleming PB
Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
[TBL] [Abstract][Full Text] [Related]
38. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
He R; Xiong S; He X; Liu F; Han J; Li J; He S
Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
[TBL] [Abstract][Full Text] [Related]
39. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
[TBL] [Abstract][Full Text] [Related]
40. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
Jen CJ; McIntire LV
Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
